跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18 条关于
“Citigroup”
全部
18
临床试验
0
药物
0
机构
1
资讯
17
去年
ArriVent BioPharma Raises $75 Million to Advance Firmonertinib and Cancer Pipeline
去年
Mirum Pharmaceuticals Raises 2025 Revenue Guidance to $490-510 Million Following Strong Q2 Performance
去年
Anthem Biosciences Raises Rs 1,016 Crore from Anchor Investors Ahead of Rs 3,395 Crore IPO
7个月前
BioAge Labs Raises $115 Million in Upsized Public Offering to Advance Metabolic Disease Pipeline
5个月前
HMH Holding Completes $210.4 Million IPO Pricing for Drilling Equipment Technology
去年
Garuda Therapeutics Names Avanish Vellanki as New CEO to Advance Off-the-Shelf Stem Cell Platform
9个月前
Medtronic Files IPO Registration for Diabetes Business MiniMed, Targeting Nasdaq Listing
去年
Hengrui Pharmaceuticals Aims to Raise $1.27 Billion in Hong Kong IPO
3个月前
FDA Accepts Vertex's Biologics License Application for Povetacicept in IgA Nephropathy, Setting November 2026 Decision Date
11个月前
EyePoint Pharmaceuticals Raises $150 Million to Advance DURAVYU Phase 3 Trials for Retinal Diseases
第 1 页,共 2 页
上一页
下一页